Harbinger Health develops innovative health technology focused on the early detection of cancer. The company offers a specialized blood test that leverages artificial intelligence and machine learning for early cancer diagnosis, allowing healthcare professionals to identify cancer before symptoms manifest.

Investors Include:

Catalyst Housing Group, Modi Ventures, M&G, Flagship Pioneering, Partners Investment, Pictet.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund